The comparison of the effect of eicosapentaenoic acid and docosahexaenoic acid in patients with helicobacter pylori infectio

Not Applicable

• Conditions: Helicobacter pylori.; Peptic ulcer, site unspecified

• Registration Number: IRCT201205262709N25
• Lead Sponsor: Gastrointestinal & Liver Disease Research Center (Firoozgar GILDRC)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

positive helicobacter pylori test result; no history of pharmaceutical treatment for infection eradication; no gastric surgery; no history of peptic ulcer; no any disease that cause inflammation & increase of serum inflammatory markers level such as diabetes, CVD, respiratoryinflammations such as asthma,...; no consumption of any drug other than prescribed drugs during the study; no consumption of antibiotic or bismut during 2 months before the trial; no consumption of antioxidant supplements such as Se, Zn, beta-caroten,... at least 3 months before the trial; no consumption of omega-3 supplements at least 3 months before the trial; no smoking; BMI less than 30; age between 20-60 years old; leaning to cooperation
Exclusion criteria: no leaning to continuing the cooperation; any change in type or dose of prescribed drugs; any change in daily diet or physical activity; consumption of any antioxidant supplement; consumption of less than 70% of supplements given to patients at the start of the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total cholesterol. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: enzymatic colorimetry.;LDL-C. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: immunotorbidometry.;HDL-C. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: immunotorbidometry.;TG. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: colorimetry.;TNF-alfa. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: enzymatic colorimetry.